Clinical Drug Studies
Do you qualify for any of our FDA regulated investigational drug studies? Our Clinical Trial Department is a front runner in cutting edge treatments for neurological disorders.
Since 2002 we have participated in the approval process of safe and effective treatments for those diagnosed with epilepsy and migraines. We have a professional and well qualified staff dedicated to bringing new options to our patients.
Please email or call our Director of Clinical Trials, Monique Bouvier, to see if you qualify.
Monique Bouvier
MBouvier@pediatricneurologypa.com
(407) 248-8282
|
|
"Clinical Studies are research studies designed to answer specific questions about medicines, devices, vaccines or new ways of using known treatments.
___________________________
These studies are conducted at hospitals, universities and doctor's offices and are the fastest and safest way to prove which treatments work best in patients."
|
|
Current Clinical Drug Studies
|
1) VANQUIX
Uncontrolled cluster seizures
Age 2 and older
Not hypersensitive/allergic to diazepam (valium)
2) LACOSAMIDE
Uncontrolled Partial-onset seizures
Age 16-70 years
Currently take 1 or 2 seizure medications
(i.e. anticonvulsant, anti epileptic, AED)
3) PERAMPANEL
Uncontrolled Partial-onset seizures
Age 12 to 18
Currently take 1 to 3 seizure medications
(i.e. anticonvulsant, anti epileptic, AED)
4) ZOMIG
History of migraines for at least 12 months
with migraine attacks of at least 2 per month
Age 12 to 17
|
|
|
|
